Trenbolone Compound Injection
- Packing: 1 Ml Amp, 10 Ml Vial, 1 Ml PFS
- Available Strength : 150 Mg/Ml,200 Mg/Ml
Description
Product Description: Trenbolone Compound Injection is a sterile solution containing a combination of trenbolone esters, including trenbolone acetate and trenbolone enanthate. It is a potent synthetic anabolic steroid designed for intramuscular administration. This formulation provides a sustained release of trenbolone, enhancing its duration of action and efficacy.
Indications and Usage: Trenbolone Compound Injection is indicated for the management of conditions characterized by muscle wasting, such as cachexia and osteoporosis. It is also used off-label to improve muscle mass and strength in athletes and bodybuilders.
Dosage and Administration: The dosage of Trenbolone Compound Injection varies depending on the individual's response to treatment, the severity of the condition being treated, and other factors. It is typically administered by intramuscular injection at a dosage ranging from 150 mg to 300 mg per week. Dosing frequency may be adjusted based on individual response and tolerance.
Dosage Forms and Strengths: Trenbolone Compound Injection is available as a sterile solution in vials. The solution is typically supplied in concentrations of 150 mg/mL.
Contraindications: Trenbolone Compound Injection is contraindicated in patients with a known hypersensitivity to trenbolone or any component of the formulation. It is also contraindicated in patients with prostate or breast cancer, hypercalcemia, and severe hepatic impairment.
Warnings and Precautions: Before initiating treatment with Trenbolone Compound Injection, healthcare providers should assess patients for contraindications and preexisting conditions, including cardiovascular disease, hepatic dysfunction, and renal impairment. Prolonged use may increase the risk of liver damage, cardiovascular events, and psychiatric disorders.
Adverse Reactions/Side Effects: Common adverse reactions associated with Trenbolone Compound Injection include hepatic dysfunction, cardiovascular effects, and psychiatric disturbances. Other potential side effects may include virilization in females, gynecomastia in males, and fluid retention.
Drug Interactions: Trenbolone Compound Injection may interact with certain medications, including anticoagulants, insulin, and corticosteroids. Concomitant use with other hepatotoxic agents may increase the risk of liver damage.
Use In Specific Populations Description: Trenbolone Compound Injection should be used with caution in pregnant and lactating women due to potential virilizing effects on the fetus or neonate. It is not recommended for use in pediatric patients, as safety and efficacy have not been established in this population.
How Supplied/Storage and Handling: Trenbolone Compound Injection is supplied as a sterile solution in vials. It should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), protected from light and moisture. Unused portions should be discarded according to local regulations for biohazardous waste disposal.
